News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Duke William E.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/25/2023 |
4
| Duke William E. (CFO) has filed a Form 4 on Apexigen, Inc.
Txns:
| Paid exercise price by delivering 26,416 shares
@ $0.3851, valued at
$10.2k
Disposed/sold 128,001 shares
@ $0 Disposed/sold 269,848 options to buy
@ $2.46, valued at
$663.8k
|
|
05/25/2023 |
4
| Duke William E. (CFO) has filed a Form 4 on Apexigen, Inc.
Txns:
| Granted 150,000 shares
@ $0 Paid exercise price by delivering 17,261 shares
@ $0.4, valued at
$6.9k
|
|
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/11/2022 |
4
| Duke William E. (CFO) has filed a Form 4 on Apexigen, Inc.
Txns:
| Granted 30,685 shares
@ $0 Granted 269,848 options to buy
@ $2.46, valued at
$663.8k
|
|
08/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/18/2022 |
4
| Duke William E. (CFO) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 44,990 restricted stock units
@ $0 Granted 125,000 restricted stock units
@ $0 |
|
09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/17/2020 |
4
| Duke William E. (CFO) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 50,000 options to buy
@ $6, valued at
$300k
|
|
12/02/2019 |
4
| Duke William E. (CFO) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns:
| Granted 270,000 options to buy
@ $8.71, valued at
$2.4M
|
|
11/22/2019 |
3
| Duke William E. (CFO) has filed a Form 3 on Kaleido Biosciences, Inc. |
05/20/2019 |
4
| Duke William E. (CFO) has filed a Form 4 on Pulmatrix, Inc.
Txns:
| Granted 160,000 options to buy
@ $1.06, valued at
$169.6k
|
|
06/06/2018 |
4
| Duke William E. (CFO) has filed a Form 4 on Pulmatrix, Inc.
Txns:
| Granted 850,000 options to buy
@ $0.468, valued at
$397.8k
|
|
03/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|